Searched for
CORBEVAX BOOSTER
Corbevax vaccine gets WHO Emergency Use Listing authorisationThe company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, ...- Biological E seeks nod for bivalent vax trialsBiological E has developed the protein subunit Covid vaccine Corbevax. The antigen used in the vaccine was developed by Texas Children’s Ho...
- 100 million doses of Corbevax supplied to Centre: Biological E LtdIn a release, the city-based vaccine maker said, "Biological E. Limited has delivered 10 crore doses of Corbevax to the Government of India...
- Vaccinated with Covaxin or Covishield? You may take Corbevax as precaution doseThe government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...
- Health Ministry likely to approve Corbevax as booster for adults vaccinated with Covishield, Covaxin"Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second do...
- NTAGI has found Corbevax efficient as a booster, govt may soon recommend it: Drug Controller General of IndiaThe National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...
- Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, CovaxinThe COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) made the recommendation in its 48th meeting hel...
- 'Corbevax under WHO's detailed review for emergency use listing'The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...
- Covid panel to decide today on inclusion of Gennova's mRNA jab in vaccine driveThe experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...
- NTAGI to decide on including Corbevax as a booster dose in inoculation drive"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...
- Corbevax may soon get nod to be used as fresh boosterIndia's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...
- Corbevax gets DCGI nod as heterologous Covid booster dose for adultsThe vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...
- Biological E seeks EUA for Corbevax as booster in adults vaccinated with Covishield, CovaxinThe Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...
- Decision on mixing and matching of booster dose of Covid vaccines will be based on science: GovtResponding to a query on whether COVID-19 vaccination will be an annual affair, Director General of Indian Council for Medical Research Bal...
- India must use more vaccines in drive, allow boosters to those willing: Experts"Data shows that in people who have taken Covishield, the protein vaccine Covovax works better as a booster than another dose of Covishield...
- The more vaccines, vaccinated the betterThe pandemic is not over. There is a need to ensure universal vaccination at home and abroad. India needs to move quickly on its domestic r...
- View: India needs to act fast to avoid flying blind into Omicron and beyondBooster doses will become available in India from January 10. The prioritisation and sequence of administration would be based on completin...
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- Indian vaccines should be used as boosters without any delay: ExpertsThis comes even as the government's advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before ...
- Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or CovaxinCurrently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...
Load More
